Selective Hyper-responsiveness of the Interferon System in Major Depressive Disorders and Depression Induced by Interferon Therapy
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Though an important percentage of patients with chronic hepatitis C virus (HCV) undergoing interferon (IFN) therapy develop depressive symptoms, the role of the IFN system in the pathogenesis of depressive disorders is not well understood. METHODS: 50 patients with HCV infection were treated with standard combination therapy (pegylated IFN-α2a/ribavirin). IFN-induced gene expression was analyzed to identify genes which are differentially regulated in patients with or without IFN-induced depression. For validation, PBMC from 22 psychiatric patients with a severe depressive episode (SDE) and 11 controls were cultivated in vitro with pegylated IFN-α2a and gene expression was analyzed. RESULTS: IFN-induced depression in HCV patients was associated with selective upregulation of 15 genes, including 6 genes that were previously described to be relevant for major depressive disorders or neuronal development. In addition, increased endogenous IFN-production and selective hyper-responsiveness of these genes to IFN stimulation were observed in SDE patients. CONCLUSIONS: Our data suggest that selective hyper-responsiveness to exogenous (IFN therapy) or endogenous (depressive disorders) type I IFNs may lead to the development of depressive symptoms. These data could lead to the discovery of novel therapeutic approaches to treat IFN-induced and major depressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“differential expression of IFN stimulated genes and genes that have been related to depression or neural development in patients that subsequently developed depression”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Schlaak et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“The severity of depression was assessed using the 17-item Hamilton Depression Rating Scale (HAMD-17) that is a common tool in clinical trials [32].”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803 · cited 1×
“0) Excel add-in was used [36].”
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“1 software [35].”
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 1×
“The IFN-a mediated depression has been widely reported in patients treated for hepatitis B, hepatitis C and malignant melanoma and can induce to suicidal behavior [7,8,10,11].”
BackgroundDiagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R., Hastie, T., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,930 · cited 1×
“1) Excel add-in to identify genes that best characterize each of two given classes (IFN induced depression or no depression) using the nearest shrunken centroid method [37].”
MethodAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., & Wachter, H. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.1.310 · Cited by 1,084 · cited 1×
“Interestingly, it has already been shown that different IFN types, including pegylated-IFN forms, are able to induce GCH1 activation with the subsequent increase of BH4 and its precursor neopterin, released from monocytes and macrophages [54,55], which has been widely used as a pharmacodynamic marker in the evaluation…”
BackgroundMaes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894 · cited 2×
“There is an increasing body of evidence that point at depression as an inflammatory disorder prompted by deregulated levels of pro-inflammatory cytokines, such interleukin-1b, IL-6, tumor necrosis factor-a, IFN-c and IFN-c-induced protein 10 (IP-10) [5–9].”
BackgroundPathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868 · cited 1×
“Around 70% of patients develop histological evidence of chronic liver disease, which may ultimately lead to liver cirrhosis and hepatocellular carcinoma [1].”
BackgroundBlackwood, D. H. R., Fordyce, A., Walker, M. T., St. Clair, D. M., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 733 · cited 1×
“Furthermore, genetic analyses revealed an association with schizophrenia and major depression [49–52].”
BackgroundTrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C.-H., Kernie, S. G., Bassel-Duby, R., & Parada, L. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.023 · Cited by 634 · cited 1×
“Recently, it has been suggested that depression may have a neurogenic origin as loss of neurons in the adult hippocampus is observed and neurogenesis is required for the actions of antidepressants [62,63].”
BackgroundActivity-Dependent Regulation of MEF2 Transcription Factors Suppresses Excitatory Synapse Number
Flavell, S. W., Cowan, C. W., Kim, T.-K., Greer, P. L., Lin, Y., Paradis, S., Griffith, E. C., Hu, L. S., Chen, C., & Greenberg, M. E. (2006) · Science · doi:10.1126/science.1122511 · Cited by 573
Foster, G. R., Goldin, R. D., & Thomas, H. C. (1998) · Hepatology · doi:10.1002/hep.510270132 · Cited by 562 · cited 1×
“severity of liver disease, hepatic encephalopathy, or history of intravenous drug use [66], it has been speculated that HCV itself may cause these alterations.”
BackgroundA schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development
Kamiya, A., Kubo, K.-I., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1328 · Cited by 531 · cited 1×
“DISC1 plays a role in neurite outgrowth and cortical development and contributes to alterations of hippocampal structure and function [47,48].”
BackgroundVariation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia
Callicott, J. H., Straub, R. E., Pezawas, L., Egan, M. F., Mattay, V. S., Hariri, A. R., Verchinski, B. A., Meyer-Lindenberg, A., Balkissoon, R., Kolachana, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500515102 · Cited by 516 · cited 1×
“DISC1 plays a role in neurite outgrowth and cortical development and contributes to alterations of hippocampal structure and function [47,48].”
BackgroundNeuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2
Mao, Z., Bonni, A., Xia, F., Nadal-Vicens, M., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5440.785 · Cited by 506 · cited 1×
“MEF2A is also involved in neuronal differentiation and postsynaptic differentiation [44–46].”
BackgroundO'Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 502
A Calcium-Regulated MEF2 Sumoylation Switch Controls Postsynaptic Differentiation
Shalizi, A., Gaudillière, B., Yuan, Z., Stegmüller, J., Shirogane, T., Ge, Q., Tan, Y., Schulman, B., Harper, J. W., & Bonni, A. (2006) · Science · doi:10.1126/science.1122513 · Cited by 458 · cited 1×
“MEF2A is also involved in neuronal differentiation and postsynaptic differentiation [44–46].”
BackgroundT Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Schlaak, J. F., Buslau, M., Jochum, W., Hermann, E., Girndt, M., Gallati, H., Büschenfelde, K.-H. M. Z., & Fleischer, B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371752 · Cited by 455 · cited 1×
“Then, PBMC were isolated as previously described [33] and cultured for 16 h in the absence or presence of 100 U/mL pegylated IFN-a2a followed by isolation of total RNA as described later.”
MethodSelf-citationChen, L., Borozan, I., Feld, J., Sun, J., Tannis, L.-L., Coltescu, C., Heathcote, J., Edwards, A. M., & McGilvray, I. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.059 · Cited by 453 · cited 1×
“Microarray studies have indicated that increased type I IFN production occurs also in the livers of HCV-infected chimpanzees and humans [73,74].”
BackgroundHepatitis C and cognitive impairment in a cohort of patients with mild liver disease
Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Wesnes, K. A., & Taylor-Robinson, S. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30688 · Cited by 450 · cited 1×
“Patients with chronic HCV infection often report fatigue, depressive mood, impaired cognitive functions, and reduced quality of life [66–68].”
BackgroundTh1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 1×
“In accordance with our mRNA data, it has been shown that plasma levels of IFN-c are higher in patients with depression [75].”
ResultEvidence for a cerebral effect of the hepatitis C virus
Forton, D. M., Allsop, J. M., Main, J., Foster, G. R., Thomas, H. C., & Taylor-Robinson, S. D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05270-3 · Cited by 333 · cited 1×
“Patients with chronic HCV infection often report fatigue, depressive mood, impaired cognitive functions, and reduced quality of life [66–68].”
BackgroundHennah, W. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg341 · Cited by 325 · cited 1×
“Furthermore, genetic analyses revealed an association with schizophrenia and major depression [49–52].”
BackgroundCapuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308 · cited 1×
“IL-6), that activate this system [20–22].”
Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction
Raison, C. L., Borisov, A. S., Broadwell, S. D., Capuron, L., Woolwine, B. J., Jacobson, I. M., Nemeroff, C. B., & Miller, A. H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0106 · Cited by 299 · cited 1×
“The IFN-a mediated depression has been widely reported in patients treated for hepatitis B, hepatitis C and malignant melanoma and can induce to suicidal behavior [7,8,10,11].”
BackgroundO'Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., & Kelley, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 295
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295 · cited 1×
“In addition, considering the previous reported association with IFN-related depression [13,18,19,38], the microarray results of IP-10 and IDO1 underwent statistical analysis.”
ResultToll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
Wu, J., Lu, M., Meng, Z., Trippler, M., Broering, R., Szczeponek, A., Krux, F., Dittmer, U., Roggendorf, M., Gerken, G., et al. (2007) · Hepatology · doi:10.1002/hep.21897 · Cited by 274
Self-citationMiller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees
Bigger, C. B., Guerra, B., Brasky, K. M., Hubbard, G., Beard, M. R., Luxon, B. A., Lemon, S. M., & Lanford, R. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13779-13792.2004 · Cited by 259 · cited 1×
“Microarray studies have indicated that increased type I IFN production occurs also in the livers of HCV-infected chimpanzees and humans [73,74].”
BackgroundPerera, T. D., Dwork, A. J., Keegan, K. A., Thirumangalakudi, L., Lipira, C. M., Joyce, N., Lange, C., Higley, J. D., Rosoklija, G., Hen, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017600 · Cited by 244 · cited 1×
“Recently, it has been suggested that depression may have a neurogenic origin as loss of neurons in the adult hippocampus is observed and neurogenesis is required for the actions of antidepressants [62,63].”
BackgroundForton, D. M., Karayiannis, P., Mahmud, N., Taylor-Robinson, S. D., & Thomas, H. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5170-5183.2004 · Cited by 242 · cited 1×
“This is supported by the fact that HCV RNA is detectable in the brain [69] or in cerebrospinal fluid leading to the hypothesis that HCV may cross the blood brain barrier by infected monocytes which could result in secondary infection of microglial cells [70].”
BackgroundZhang, P., Papenfuss, T. J., Wake, M. H., Qu, L., & Wake, D. B. (2008) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2008.08.020 · Cited by 238 · cited 1×
“, IDO1, serotonin receptor and transporter polymorphisms [24–27], and IL-6 polymorphisms [24], reviewed in [28]).”
BackgroundBull, S. J., Huezo-Diaz, P., Binder, E. B., Cubells, J. F., Ranjith, G., Maddock, C., Miyazaki, C., Alexander, N., Hotopf, M., Cleare, A. J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.48 · Cited by 228 · cited 1×
“, IDO1, serotonin receptor and transporter polymorphisms [24–27], and IL-6 polymorphisms [24], reviewed in [28]).”
BackgroundFelger, J. C., Alagbe, O., Hu, F., Mook, D., Freeman, A. A., Sanchez, M. M., Kalin, N. H., Ratti, E., Nemeroff, C. B., & Miller, A. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.026 · Cited by 214
Type I Interferon Modulates Monocyte Recruitment and Maturation in Chronic Inflammation
Lee, P. Y., Li, Y., Kumagai, Y., Xu, Y., Weinstein, J. S., Kellner, E. S., Nacionales, D. C., Butfiloski, E. J., van Rooijen, N., Akira, S., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090328 · Cited by 182 · cited 1×
“the role of type I IFNs is still not well understood, it has been reported that they may help sustain the chronic inflammatory response promoting the recruitment of inflammatory monocytes [76] which may be involved in the pathophysiology of the depressive symptoms.”
BackgroundAsnis, G. M., & De La Garza, R. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000210099.36500.fe · Cited by 170 · cited 2×
“In recent studies using pegylated interferon (IFN)-a2 in combination with ribavirin response rates for genotype 1 patients were approximately 40–50% while patients with genotype 2 or 3 respond in about 80–90% [2–4].”
BackgroundKitagami, T., Yamada, K., Miura, H., Hashimoto, R., Nabeshima, T., & Ohta, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02776-8 · Cited by 163 · cited 1×
“Studies in experimental animals have revealed that IFN-a, when injected into the ventricular system, can suppress serotonin (5-HT) and dopamine levels in the striatum, frontal cortex and midbrain [12,14].”
BackgroundMorikawa, O., Sakai, N., Obara, H., & Saito, N. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00187-3 · Cited by 160 · cited 3×
“Moreover, it has been shown that IFN-a is a potent inducer of mitogen activated protein kinase (MAPK) signaling pathways [18], that have been reported to activate monoamine transporters and thereby deplete their synaptic concentrations [13,19].”
BackgroundResultDetection and Analysis of Hepatitis C Virus Sequences in Cerebrospinal Fluid
Laskus, T., Radkowski, M., Bednarska, A., Wilkinson, J., Adair, D., Nowicki, M., Nikolopoulou, G. B., Vargas, H., & Rakela, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.10064-10068.2002 · Cited by 153 · cited 1×
“This is supported by the fact that HCV RNA is detectable in the brain [69] or in cerebrospinal fluid leading to the hypothesis that HCV may cross the blood brain barrier by infected monocytes which could result in secondary infection of microglial cells [70].”
BackgroundHuber, C., Fuchs, D., Hausen, A., Margreiter, R., Reibnegger, G., Spielberger, M., & Wachter, H. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.3.1047 · Cited by 152 · cited 1×
“Interestingly, it has already been shown that different IFN types, including pegylated-IFN forms, are able to induce GCH1 activation with the subsequent increase of BH4 and its precursor neopterin, released from monocytes and macrophages [54,55], which has been widely used as a pharmacodynamic marker in the evaluation…”
BackgroundKaneko, N., Kudo, K., Mabuchi, T., Takemoto, K., Fujimaki, K., Wati, H., Iguchi, H., Tezuka, H., & Kanba, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301137 · Cited by 152 · cited 1×
“Furthermore, it has been demonstrated that exogenous administration of IFN-a suppressed neuronal proliferation via proinflammatory cytokines IL-1b and TNF-a in the hippocampus of adult rats [64].”
BackgroundChuang, J.-Z., Yeh, T., Bollati, F. A., Conde, C. B., Canavosio, F., Cáceres, A., & Sung, C.-H. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.04.003 · Cited by 138 · cited 1×
“DYNLT1 (alternative name: TCTEL1) plays a key role in multiple steps of hippocampal neuron development such as neurite sprouting, axon specification and dendritic elaboration [43].”
BackgroundWichers, M., Kenis, G., Koek, G. H., Robaeys, G., Nicolson, N. A., & Maes, M. H. J. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.09.007 · Cited by 135 · cited 1×
“IL-6), that activate this system [20–22].”
Raison, C. L., Broadwell, S. D., Borisov, A. S., Manatunga, A. K., Capuron, L., Woolwine, B. J., Jacobson, I. M., Nemeroff, C. B., & Miller, A. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.05.001 · Cited by 131
Loftis, J. M., Huckans, M. S., Ruimy, S., Hinrichs, D. J., & Hauser, P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.001 · Cited by 127 · cited 1×
“Latter findings even related specifically increased plasma levels of the mentioned cytokines to the cause of severe depressive symptoms in HCV patients [65].”
BackgroundIncreased risk for recurrent major depression in DYT1 dystonia mutation carriers
Heiman, G. A., Ottman, R., Saunders-Pullman, R. J., Ozelius, L. J., Risch, N. J., & Bressman, S. B. (2004) · Neurology · doi:10.1212/01.wnl.0000137113.39225.fa · Cited by 119
A Novel PEGylated Interferon Beta‐1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
Hu, X., Miller, L., Richman, S., Hitchman, S., Glick, G., Liu, S., Zhu, Y., Crossman, M., Nestorov, I., Gronke, R. S., et al. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011407068 · Cited by 118 · cited 1×
“Interestingly, it has already been shown that different IFN types, including pegylated-IFN forms, are able to induce GCH1 activation with the subsequent increase of BH4 and its precursor neopterin, released from monocytes and macrophages [54,55], which has been widely used as a pharmacodynamic marker in the evaluation…”
BackgroundKraus, M. R., Al‐Taie, O., Schäfer, A., Pfersdorff, M., Lesch, K., & Scheurlen, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.053 · Cited by 116
Systemic interferon-α regulates interferon-stimulated genes in the central nervous system
Wang, J., Campbell, I. L., & Zhang, H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002013 · Cited by 108 · cited 1×
“Further studies in mice have suggested that systemic IFNa treatment may also have a direct effect by upregulating IFNstimulated genes (ISGs) in the brain with a profile very similar to peripheral organs [31].”
BackgroundKamata, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00067-x · Cited by 105 · cited 2×
“As cytokines affect the synthesis, release and cellular reuptake of monoamines and their dysregulation affects several central nervous system functions, it has been postulated that some neurophysiologic changes that affect activity of the noradrenergic and/or the serotonergic neuron system may occur during IFN therapy…”
BackgroundSawamura, N., Sawamura-Yamamoto, T., Ozeki, Y., Ross, C. A., & Sawa, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406543102 · Cited by 105 · cited 1×
“Furthermore, genetic analyses revealed an association with schizophrenia and major depression [49–52].”
BackgroundToll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication
Broering, R., Wu, J., Meng, Z., Hilgard, P. A., Lu, M., Trippler, M., Szczeponek, A., Gerken, G., & Schlaak, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.028 · Cited by 101
Self-citationGenes, Environment, and Individual Differences in Responding to Treatment for Depression
Uher, R. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.586551 · Cited by 92 · cited 1×
“Some of them are widely studied in case of idiopathic depression as well (reviewed in [29]).”
BackgroundGanglioside GM3 is involved in neuronal cell death
Sohn, H., Kim, Y.-S., Kim, H.-T., Kim, C., Cho, E., Kang, H., Kim, N.-S., Kim, C., Ryu, S. E., Lee, J. H., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4911fje · Cited by 87 · cited 1×
“ST3GAL5 is involved in neuronal apoptotic cell death in mouse hippocampal cell lines [53].”
BackgroundSmith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Cellular Distribution of Torsin A and Torsin B in Normal Human Brain
Konakova, M., Huynh, D. P., Yong, W. H., & Pulst, S. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.6.921 · Cited by 83 · cited 1×
“TOR1B, which shows immunoreactivity in all subfields of the hippocampus [41], is homologue to TOR1A (alternative name: DYT1), is associated with early-onset recurrent major depression and is involved in the regulation of dopamine release [42].”
BackgroundRole of Toll-like receptors in liver health and disease
Broering, R., Lu, M., & Schlaak, J. F. (2011) · Clinical Science · doi:10.1042/cs20110065 · Cited by 83 · cited 1×
“Interestingly, we also found an upregulation of TLR3 and TLR7 that function as sensors of the innate immune system for viral structures in particular, reviewed in [39].”
BackgroundSelf-citationElomaa, A.-P., Niskanen, L., Herzig, K.-H., Viinamäki, H., Hintikka, J., Koivumaa-Honkanen, H., Honkalampi, K., Valkonen-Korhonen, M., Harvima, I. T., & Lehto, S. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-2 · Cited by 62 · cited 1×
“In fact, the monocyte-T-lymphocyte hypothesis of mayor depression predicts an immune system activation subjacent to the pathophysiology of major depressive disorder [40], and the association of the depressive symptoms with an increased production of proinflammatory cytokines [5–8] may indicate that they are the result…”
BackgroundHahn, H., Trant, M. R., Brownstein, M., Harper, R. A., Milstien, S., & Butler, I. J. (2001) · Archives of Neurology · doi:10.1001/archneur.58.5.749 · Cited by 59 · cited 1×
“Clinically, alterations of GCH1 activity has been associated with bipolar disorders, depression, anxiety, dystonia and deafness [60,61].”
BackgroundMolecular genetics of bipolar disorder
Kato, T. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00221-8 · Cited by 53
Kanda, T., Steele, R., Ray, R., & Ray, R. B. (2007) · Journal of Virology · doi:10.1128/jvi.01695-07 · Cited by 48 · cited 1×
“It is well known that HCV can activate the production of IFN-b through activation of the Tolllike receptor system [71,72], which explains the strong upregulation of IFN-b in the peripheral blood of HCV patients in our study.”
BackgroundPasquali, S., & Mocellin, S. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793176393 · Cited by 40
Risk factors for the development of depression in patients with hepatitis C taking interferon-α
Smith, K. J., Norris, S., O’Farrelly, C., & O’Mara, S. M. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13917 · Cited by 39 · cited 1×
“, IDO1, serotonin receptor and transporter polymorphisms [24–27], and IL-6 polymorphisms [24], reviewed in [28]).”
SHIMIZU, H., OHTANI, K.-I., SATO, N., NAGAMINE, T., & MORI, M. (1995) · Endocrine Journal · doi:10.1507/endocrj.42.551 · Cited by 38
Yoshida, K., Alagbe, O., Wang, X., Woolwine, B., Thornbury, M., Raison, C. L., & Miller, A. H. (2005) · Neuropsychobiology · doi:10.1159/000086605 · Cited by 37
Zoller, H., Schloegl, A., Schroecksnadel, S., Vogel, W., & Fuchs, D. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0093 · Cited by 33
Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells
Zhao, L., Hua, X., He, S.-F., Ren, H., & Qi, Z. (2011) · Virology Journal · doi:10.1186/1743-422x-8-157 · Cited by 31 · cited 2×
“Moreover, it has been shown that IFN-a is a potent inducer of mitogen activated protein kinase (MAPK) signaling pathways [18], that have been reported to activate monoamine transporters and thereby deplete their synaptic concentrations [13,19].”
BackgroundResultKealey, C., Roche, S., Claffey, E., & McKeon, P. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30192 · Cited by 22 · cited 1×
“Clinically, alterations of GCH1 activity has been associated with bipolar disorders, depression, anxiety, dystonia and deafness [60,61].”
BackgroundA Biological Approach to Optimize Interferon Treatment in Hairy Cell Leukemia
Gastl, G. A., Aulitzky, W. E., Tilg, H., Nachbaur, K., Troppmair, J., Flener, R., & Huber, C. (1986) · Immunobiology · doi:10.1016/s0171-2985(86)80107-3 · Cited by 20 · cited 1×
“Interestingly, it has already been shown that different IFN types, including pegylated-IFN forms, are able to induce GCH1 activation with the subsequent increase of BH4 and its precursor neopterin, released from monocytes and macrophages [54,55], which has been widely used as a pharmacodynamic marker in the evaluation…”
BackgroundBezemer, G., Gool, A. R. V., Fekkes, D., Vrolijk, J., Hansen, B. E., Janssen, H. L. A., & de Knegt, R. J. (2012) · Neuropsychobiology · doi:10.1159/000330585 · Cited by 11 · cited 1×
“Even more, several authors have lately reported that IFN-a therapy impairs phenylalanine metabolism in HCV infected individuals [58,59], suggesting that behavioural side effects may be associated with the modulation of BH4 levels, thus affecting dopamine, serotonin and noradrenaline biochemistry.”
Background[Molecular genetics of bipolar disorder].
Kato, T., & Kato, N. (1999) · PubMed · Cited by 4
Research works printed but not linked: 1
- Wong ML Dong C Maestre-Mesa J Licinio J 2008 Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 13 800 812 18504423 PMC2650233 · DOI · Paper page
Cited by
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
“For example, one study that examined early (initial injection) changes in the response to IFNalpha administration reported differential expression of IFN stimulated genes and genes that have been related to depression or neural development in patients that subsequently developed depression (Schlaak et al., 2012).”
BackgroundReisinger, S., Khan, D., Kong, E., Berger, A., Pollak, A., & Pollak, D. D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.001 · Cited by 224
Mostafavi, S., Battle, A., Zhu, X., Potash, J. B., Weissman, M. M., Shi, J., Beckman, K., Haudenschild, C., McCormick, C., Mei, R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.161 · Cited by 187
“32 There are two reports from a larger study that included microarray whole-transcriptome and GWAS data for 215 MDD cases and their relatives (San Antonio Family Heart Study): RNF123 was the most signi fi cant gene in a bivariate linkage analysis of MDD and gene expression values ( P >0.5 here); 50…”
BackgroundInfluentialLiu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119
“PBMCs isolated from patients admitted Frontiers in Neuroscience | Neuroendocrine Science September 2014 | Volume 8 | Article 309 | 8 for severe depressive episodes are more responsive to interferon-γ (IFN-γ) stimulation (Schlaak et al., 2012).”
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 131
Self-citation
Metadata
- Authors
- Schlaak, J. F., Trippler, M., Hoyo-Becerra, C., Erim, Y., Kis, B., Wang, B., Scherbaum, N., & Gerken, G.
- Affiliations
- Essen University Hospital (DE)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-06
- Volume
- 7
- Issue
- 6
- Pages
- e38668
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3368901
- OpenAlex
- W1976017826
- Cited by
- 25
- References
- 77
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 7 · 2015: 2 · 2014: 3 · 2013: 5
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- interferon therapy, interferon-induced depression, major depressive disorder, hepatitis C virus, pegylated interferon alpha-2a, ribavirin, type I interferon, interferon-induced gene expression, peripheral blood mononuclear cells
- MeSH terms
- Interferon alpha-2, Adult, Major Depressive Disorder, Female, Gene Expression Regulation, Humans, Leukocytes, Mononuclear, Male, Middle Aged, Prospective Studies, Recombinant Proteins, Case-Control Studies, Interferon-alpha, DNA Primers, Statistics, Nonparametric, Hepatitis C, Chronic, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Microarray Analysis, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.